Bain Capital

Bain Capital, established in 1984, is a global multi-asset alternative investment firm with over $100 billion in assets under management. Headquartered in Boston, Massachusetts, the firm operates through several business units: Private Equity, Public Equity, Credit, and Venture Capital. Bain Capital Private Equity invests in various sectors, including consumer, healthcare, industrials, and technology, across North America, Europe, and Asia. Bain Capital Ventures, the venture capital arm, focuses on seed to growth-stage investments in enterprise software, infrastructure software, and industries being transformed by data. Bain Capital Life Sciences, a dedicated life sciences investment platform, invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies globally. Bain Capital Double Impact, the firm's impact investing arm, builds great companies that deliver both competitive financial returns and meaningful, measurable social and environmental good.

Darren Abrahamson

Managing Director

Ajay Agarwal

Partner

Thomas Allen

Principal

Eric Anderson

Managing Director and Member of the North American Private Equity Team

Maria Andrisani

Partner, Private Equity

Ernesto Anguilla

Partner and Head of Communications and Public Affairs

Tim Anten

Managing Director and Member of the European Private Equity Team

Melaku Arega

Associate

Carlos Argilagos

Director

Emily Ashworth

Managing Director, Operating Partner of Portfolio Group and Member of the North American Private Equity team

Lorenzo Bartolini

Associate

James Bath

Operating Partner in the Portfolio Group and Member of the European Private Equity team

Jonathan Belitsos

Partner, Private Equity

Nicholas Bendt

Managing Director of Industrial and Energy Vertical and a Member of the European Private Equity team

Saahil Bhatia

Managing Director, Private Equity and Member of the Asia Pacific Private Equity team

William Bihrle

Managing Director, Technology, Media, Telecommunications and Private Equity and Member Of The North American Private Equity Team

Riker Bixby

Associate

Brooks Blake

Investment Director and Partner, Investments

Allison Braley

Partner

Jakob Brevinge

Principal

Andrej Busch

Partner, Private Equity and Member of the European Private Equity team

Giovanni Camera

Partner, Technology Financial and Business Services and Member of the European Private Equity team

Phillip Carter

Managing Director

Jonah Cashdan

Principal

Hui Chan

Managing Director, Consumer, Retail and Dining Vertical, Member of the European Private Equity Team and Member of the Recruiting Team

Hunter Chang

Associate

Cecilia Chao

Partner, Double Impact Team

Bradley Charchut

Partner

Daniel Charnoff

Principal, Industrials and Member of the North American Private Equity Team

Shuvam Chaudhuri

Associate

Drew Chen

Partner, Private Equity, Technology, Media and Telecommunications Vertical and Founding Member Of The Asian Pacific Private Equity Team

Mary Chen

Associate

Daisy Chen

Managing Director

Leong Cheung

Operating Partner

John Paul (JP) Chilazi

Managing Director of Healthcare Vertical and Member of the North American Private Equity Team

Mike Choi

Managing Director, Private Equity and Member of the Asian Private Equity Team

Kevin Chong

Partner, Special Situations and Head of Special Situations Portfolio Group

Kei W. Chua

Partner, Special Situations

Tan Chuqiao

Partner

Davis Clayson Jr.

Managing Director

Alysaa Co

Associate

Alysaa Co

Principal

Stefan Cohen

Partner

Zeeza Cole

Investor

Amanda Conklin

Vice President, Double Impact

Todd Cook

Partner

Michael Cooney

Associate

Jay Corrigan

Group Co-CFO

Pascal Croak

Investor

Leslie Crowe

Partner

Frank D'Hollander

Operating Partner

Jennie Daisak

Vice President

Jennifer Davis

Partner, Private Equity, Consumer and Retail Vertical and Member of the North American Private Equity Team

Nathaniel Denby

Vice President

Clarence Deng

Principal, Member of the Consumer and Technology verticals on the Asia Pacific Private Equity

David DesPrez

Managing Director, Special Situations

Wayne Deveydt

Managing Director

Tina Dimitrova

Principal

Christina Dix

Partner, Healthcare Vertical and Member of European Private Equity team

Arnaud Doerane

Managing Director, Private Equity, Technology Financial and Business Services Vertical and Member of the European Private Equity Team

Jacob Donnelly

Partner

David Edelson

Managing Director of Portfolio Group and Member of the North American Private Equity

Erin Endres

Associate

Eric Erb

Partner and Member of the Asian Pacific Private Equity

Liraz Evenor

Managing Director Private Equity and Director in the Consumer and Retail Vertical & Member of the Portfolio Group for North America Private Equity

Andy Fan

Principal

Robert Farkas

Partner, Private Equity and Member of the North American Private Equity Team

Leonard Feiner

Principal

Valentin Fernandez

Principal, Private Equity and Member of the North American Private Equity Team

William Van Fossen

Associate

Jorge Fournier

Vice President

Matt Freeman

Partner, Private Equity and Member of The North American Private Equity Team

Michel Freund

Partner and Member of the North American Private Equity Team

Rak Garg

Partner

Nick Gattas

Principal, Asian Pacific Private Equity team

Francois Gilbart

Operating Partner, Private Equity

Jeffrey Green MD

Partner

Evan Greif

Principal, Life Sciences

Max de Groen

Partner, Private Equity

Kevin Guan

Managing Director, Private Equity

Andrew Hack

Partner

Soren Haefcke

Principal

Dave Hamilton

Partner and Co-Head of Information Technology

Ingrid Hammond

Operating Partner, Portfolio Group and Member of the North American Private Equity Team

Kristie Han

Principal

Alena Harrison

Operating Partner

Joshua Hartz

Partner, Special Situations

Ray Hass

Managing Director and Member of the Asia Pacific Portfolio Group

Dawit Heck

Principal

Blair Hendrix

Partner and Head, North American Private Equity Portfolio Group

Darren Herman

Managing Director, Private Equity and Member of the North American Private Equity team

Sarah Hinkfuss

Partner

Alison Holmes

Principal, Private Equity and Consumer, Retail and Dining Vertical & Member of the North American Private Equity Team

Hajime Honda

Managing Director and Member of the Asia Pacific Private Equity Team

Halvor Meyer Horten

Partner, Industrials Vertical and Member of the European Private Equity team

Olivia Howard

Partner

David Humphrey

Partner, Global Head of the Technology, Media and Telecommunications Vertical and Co-Head of Bain Capital's North American Private Equity

Jonathan Humphrey

Managing Director, Global Macro and Asset Allocation group

Abhiroop Jayanthi

Managing Director and Member of the Asian Pacific Private Equity team

Cristian Jitianu

Partner, Private Equity, Consumer, Retail and Dining and Financial and Business Service Verticals

Philippe Kamel

Principal of European Private Equity Team

Masafumi Kamishiro

Operating Partner, Portfolio Group and Member of the Asian Pacific Private Equity team

Andrew Kaplan

Partner, Private Equity and Healthcare Vertical and Member Of The North American Private Equity Team

Christopher Kastner

Managing Director, Portfolio Group and Member of the North American Private Equity team

Nick Kazarinoff

Principal, Healthcare Vertical and Member of the European Private Equity Team

James Kellog

Managing Director

Liam Kennedy

Partner and Corporate Controller

Kevin Kerby

Managing Director, Private Equity and Member of the North American Private Equity Team

Victoria Khanna

Partner, Investor Relation

Tomohiro Kikuta

Partner

Hyunseung Kim

Managing Director, Portfolio Group and Member of the Asian Pacific Private Equity Team

Ryuto Kobayashi

Managing Director

Klaus Koenigshausen

Partner

Takatoshi Kojima

Principal, Private Equity and Member of the Asia Pacific Private Equity Team

Hayato Kondoh

Principal and Member of the Asia Pacific Private Equity team

Joshua de Kroes

Principal, Industrials and Member of the European Private Equity

Michael Krupka

Partner

Hisashi Kubodera

Principal and Member of the Asian Pacific Private Equity Team

Ajay Kumar

Managing Director, Private Equity, Industrial and Energy Vertical and Member Of The North American Private Equity Team

Christina Kyriazi

Partner

Komi Kyu

Managing Director and Member of the Asia Pacific Private Equity Team

Charles Lawson

Managing Director and Member of the Asian Pacific Private Equity Team

Jungwoo Lee

Partner, Industrial and Technology, Media and Telecommunications and Member of the Asia Pacific Private Equity and Special Situations teams

Casey Leonetti

Managing Director, Private Equity

Adam Levin

Partner

Susan Levine

Partner, Private Equity and Member Of The North American Private Equity Team

Angela Liu

Associate

Carolyn Liu

Managing Director

Andrew Liu

Executive Vice President of Asia Portfolio Group

Zihan Liu

Principal

Cara Lorion

Managing Director, Partner and Co-CFO for Coinvest, GP and Partner Services

Phillip Loughlin

Partner, Global Head of the Financial and Business Services Vertical and Member of the Consumer / Retail Vertical

James Mackey

Principal, Private Equity and Technology Vertical and Member of the North American Private Equity Team

Vibhu Manya

Operating Partner, Private Equity and Member of the Asian Pacific Private Equity Team

Francesco Marra

Managing Director, Portfolio Group and Member of the European Private Equity team

Giacomo Massetti

Managing Director, Consumer and Industrial Verticals and Member of the European Private Equity team

Kimberly McCaslin

Partner, Private Equity and Head of the North America Portfolio Group

Greg Mervine

Associate

Abby Meyers

Principal

Grace Mollard

Managing Director, Consumer, Retail and Restaurant Vertical and Member Of The North American Private Equity Team And Recruiting Team

Sarah Morris

Managing Director of Portfolio Group and Member of the European Private Equity Team

Paul Moskowitz

Managing Director, Private Equity and Healthcare Vertical and Member Of The North American Private Equity Team

Colin Motley

Managing Director, Technology, Media, Telecom Vertical and Private Equity and Member Of The North American Private Equity Team

Mike Murphy

Partner, Private Equity

Maurizio Mussi

Partner, Private Equity and Member of the European Private Equity Team

Shunsuke Nakahama

Partner and Member of the Portfolio Group for the Asia Pacific Private Equity

Cara Nealon

Senior Vice President, Portfolio Group and Member of the North American Private Equity Team

Adam Nebesar

Partner, Private Equity and Consumer, Retail and Dining Vertical and Member Of The North American Private Equity Team

Petr Nosek

Principal

Devin O'Reilly

Partner, Private Equity and Head of the Healthcare Vertical

Kazunari Obama

Principal, Private Equity Tokyo

Martha Obasi

Vice President

Saanya Ojha

Partner

Fatima Olalla

Principal, European Private Equity Team

Nicholas Onie

Principal of Asia Pacific Private Equity Team

Kenichi Ota

Principal, Private Equity and Member of the Asia Pacific Private Equity Team

Kohei Otani

Principal, Asia Pacific Private Equity Team

Jeff Otis

Operating Partner, Private Equity and Portfolio Group and Member Of The North American Private Equity Team

Jie Pan

Operating Partner

Minju Park

Principal, Special Situations

Hardi Patel

Associate

Sam Payne

Principal, Private Equity and Member of the Asian Pacific Private Equity Team

Gregory Petros

Principal, Healthcare Vertical and Member of the European Private Equity team

Benjamin Prawdzik

Vice President, Consumer and Financial and Business Services Verticals

Marc Pulde

Principal, Industrial and Energy Vertical and Member Of The North American Private Equity Team

Chen Qian

Managing Director and Member of the Asian Pacific Private Equity Team

Larissa Quinn

Operating Partner

Gianni Renzi

Associate

Peter Riehl

Managing Director

Allyson S. Rinderle

Managing Director

Allyson Rinderle

Managing Director

Steve Rizoli

Principal

Joseph Robbins

Partner, Private Equity and Industrial Vertical and Member of the North American Private Equity Team

Mitt Romney

Founder

Joshua Ross

Managing Director

Douglas Rudisch

Managing Director

Mark Saadine

Managing Director of Consumer, Retail and Dining Vertical and Member of the North American Private Equity Team

Jérémie Saiman

Principal of European Private Equity Team

Enrique Salem

Partner

Youssef Salha

Partner, Private Equity and Member of the European Private Equity team

Linas Samuolis

Principal, Special Situations Team

Tom Sargeant

Partner

Matt Sears

Principal

Dominik Seitz

Principal

Ivano Sessa

Partner, European Co-Head of the Industrial Vertical and Member of the European Private Equity Team

Hajime Shimazu

Managing Director and Member of the Asian Pacific Private Equity Team

Harry Simpson

Vice President

Ari Singer-Freeman

Associate

Pavninder Singh

Partner, Private Equity, Financial and Business Services and Industrial and Energy Verticals and Member Of The Asian Pacific Private Equity Team

David Spiller JD

Partner of Portfolio Group and Member of the North American Private Equity Team

Peter Spring

Partner, Double Impact

David Steiner

Vice President of Real Esate

Slater Stich Ph.D

Partner

Zhao Su

Principal

Pooja Subramaniam

Associate

Radhika Subramanian

Principal, Consumer, Retail and Financial services and a Member of the Asia Pacific Private Equity team

Ricky Sun

Partner

Mark Sutton

Chief Information Security Officer and Managing Director

Junichi Takami

Executive Vice President, Portfolio Group and Member of the Asian Pacific Private Equity team

Yuji Takei

Partner, Private Equity

James Tam

Partner and Managing Director, Private Equity Team, Greater China

Will Tetler

Managing Director, Special Situations

Aurelia Tichoux

Operating Partner of Portfolio Group and Member of the European Private Equity Team

Miray Topay

Partner, Private Equity

John Toussaint

Managing Director

Pierre-Henri Vacher-Lavenu

Principal

Davide Vidotto

Principal, Private Equity and Member of the European Private Equity team

Paolo Massimiliano Maria Vismara

Managing Director, Portfolio Group and Member of the European Private Equity team

Shunsuke Wakita

Principal and Member of the Asian Pacific Private Equity Team

Nigel Walder

Partner, Private Equity

Danielle Wang

Operating Partner of Portfolio Group Portfolio Group and Member of the North American Private Equity Team

Renjie Wang

Managing Director and Member of the Asia Pacific Private Equity Team

Michael Ward

Managing Director, COO and CFO

Shun Watanabe

Managing Director, Portfolio Group and Member of the Asian Pacific Private Equity team

Harris Weber

Principal

Sam Weil

Principal, Private Equity and Member Of The North American Private Equity Team

Phil Wieland

Operating Partner

Shena Willis

Principal, Private Equity and Member of the European Private Equity Team

ELi Winkler

Managing Director, Private Equity

Patricia Winton

Partner and Head of ESG

Natalie Wright

Partner and Head of Investment Operations, Private Equity

Ray Xi

Managing Director

Frank Yao

Managing Director

Takumi Yoshikawa

Operating Partner and Member of the Asian Pacific Private Equity Team

Martina Yu

Principal, Private Equity and member of the Asian Pacific Private Equity team

Lina Zhou

Principal, Private Equity, Consumer, Retail and Dining vertical and Member of European Private Equity team

Jack Zhu

Vice President

Paul Zurlo

Operating Partner

Charles Megaw Ph.D

Partner, Private Equity and Member of Portfolio Group for Europe Private Equity

Jack Sun

Managing Director

Will Cozean

Managing Director

Amir Zamani

Managing Director

Zhenyu Zhang Ph.D

Managing Director and Member of the Asian Pacific Private Equity Team

1006 past transactions

Astronomer

Series D in 2025
Astronomer, Inc. is a company based in Cincinnati, Ohio, that specializes in developing a managed platform for data orchestration, primarily utilizing Apache Airflow. Established in 2014, Astronomer offers a comprehensive suite of products and services through its platform, known as Astro. This platform is designed to streamline the process of building, running, and monitoring data pipelines-as-code, catering to the needs of data engineers, scientists, and analysts. By providing tools for deploying, managing, and scaling data workflows, Astronomer enhances the availability of trusted data for organizations, making it easier for data teams to conduct business analytics effectively. As a commercial developer of Airflow, Astronomer plays a significant role in the data orchestration landscape, serving hundreds of thousands of teams globally.

Structify

Seed Round in 2025
Structify is a technology company that specializes in data extraction and structuring. It offers a platform that enables businesses to create custom datasets by specifying the data format, selecting the source(s), and assigning agents to search and extract the data. The company's in-house model ensures the quality and accuracy of the extracted data across various use cases. Structify has found applications in finance, construction, and corporate technology, helping teams extract and organize data from diverse sources such as pitch decks, geotechnical documents, and real-time chain of command data.

Navro

Series B in 2025
Navro is a fintech company that specializes in providing payment and banking infrastructure for software businesses. It offers a platform that enables brands to scale their payment operations globally by integrating various financial services such as international payment acceptance, local fund collection, and real-time coverage. Navro's solution allows businesses to manage their payment stack efficiently, facilitating international growth.

BitradeX

Series A in 2025
BitradeX is a technology company specializing in digital asset trading. It operates an AI-powered trading platform that leverages innovative algorithms and blockchain technology to enhance the trading experience. The platform offers intelligent automation, robust compliance measures, and a user-centric design, aiming to provide a secure, efficient, and intelligent trading ecosystem for its users.

Lincoln Financial Group

Post in 2025
Lincoln Financial Group is a Fortune 500 insurance and financial services company based in Radnor, Pennsylvania, established in 1905 with the endorsement of Robert Todd Lincoln, the son of Abraham Lincoln. The company is dedicated to providing a wide range of products, including life insurance, annuities, retirement plan services, and group protection. It focuses on wealth protection, accumulation, and retirement income solutions, aiming to help individuals secure better futures for themselves and their families. With over a century of experience, Lincoln Financial Group has built its reputation on the principles and ideals associated with Abraham Lincoln, emphasizing honesty and dependability in its financial services.

Sizzling Platter

Acquisition in 2025
Sizzling Platter, LLC is a food and beverage company that owns and manages a diverse portfolio of fast casual restaurants in the United States and internationally. Founded in 1963 and headquartered in Murray, Utah, the company offers a variety of menu items, including pizzas, donuts, coffee, burgers, steak, seafood, and salads, catering to a wide range of tastes. Sizzling Platter focuses on acquiring and supporting restaurant brands, providing them with resources for growth and financial success. The company also emphasizes social responsibility by donating food to those in need on designated days. Through its commitment to delivering exceptional dining experiences and supporting its brand partners, Sizzling Platter aims to establish itself as a leading franchise platform in the food service industry.

Merida Biosciences

Series A in 2025
Merida Biosciences is a biotechnology company specializing in the development of precision therapies for autoimmune diseases. It employs a protein engineering platform to create novel Fc therapeutics, which selectively target and neutralize specific antibodies, aiming to treat the root cause of antibody-driven diseases with high precision and durability.

HealthEdge

Acquisition in 2025
HealthEdge is a technology company that provides an integrated software platform designed for healthcare payors. Founded in December 2004 by Albert Waxman and Rob Gillette, HealthEdge specializes in delivering innovative solutions that help health insurers enhance operational efficiency, improve patient outcomes, and significantly lower administrative costs. The company's flagship product suite, HealthRules, is built on patented technology and can be deployed via the HealthEdge Cloud or on-premises. This platform encompasses various functionalities, including claims and benefits administration, care management, and business intelligence, enabling clients to adopt new business models and streamline processes within the healthcare delivery system. In 2012, HealthEdge expanded its offerings by acquiring Click4Care, which enhanced its capabilities in clinical care management. Headquartered in Burlington, Massachusetts, HealthEdge also has a research and development center in Powell, Ohio.

KREA

Series B in 2025
KREA is an artificial intelligence platform that empowers users to create images from text prompts and save them into personalized collections. By offering access to millions of AI-generated images, KREA enables individuals to find inspiration for their projects. The platform also allows users to train a customized AI model using their own images, ensuring that the generated content aligns with their unique style and preferences.

Atsena Therapeutics

Series C in 2025
Atsena Therapeutics is a clinical-stage gene therapy company dedicated to developing innovative treatments for inherited retinal diseases. The company focuses on therapies for conditions such as X-linked retinoschisis and GUCY2D-associated Leber congenital amaurosis. Utilizing an advanced adeno-associated virus (AAV) technology platform, including a novel spreading capsid, Atsena aims to target specific retinal conditions to prevent blindness resulting from genetic mutations. Their research is centered on providing effective ocular gene therapies that address significant challenges associated with inherited retinal diseases, with the goal of reversing or halting vision loss.

Actively AI

Series A in 2025
Actively AI is a technology company founded by researchers from Stanford University, specializing in an artificial intelligence-based outbound sales platform. The company aims to enhance lead generation and prospecting efficiency for sales teams by offering features such as automated account research and real-time identification of top prospects. Additionally, Actively AI provides personalized messaging generation based on data insights, which enables organizations to significantly increase their sales pipeline and improve meeting booking rates. By streamlining these processes, the platform allows sales representatives to concentrate on engaging with potential clients, ultimately driving better sales outcomes.

LightSource

Series A in 2025
LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work. The company was founded in 2021 and is headquartered in San Francisco, California.

Straiker

Series A in 2025
Straiker is a technology company that specializes in AI-native security solutions. It develops AI risk assessment software to enhance security through one-time or continuous testing. The company's technology simulates attacks against AI applications and agents, conducting a suite of security checks to identify and mitigate critical AI risks, providing protection beyond prompt-level threats and enabling automated threat blocking.

Namirial

Acquisition in 2025
Namirial is a developer of digital transaction management software that facilitates the complete digital transformation of business processes for private sector companies and public administration organizations. The company's platform encompasses a range of services, including identity management, electronic signatures, certified communication, document management, electronic invoicing, and cybersecurity. By integrating these solutions, Namirial enables organizations to efficiently manage and execute both internal and external document-centric transactions in a fully digital environment, enhancing operational efficiency and security.

HeartFlow

Convertible Note in 2025
HeartFlow Inc., established in 2007 and headquartered in Redwood City, California, specializes in non-invasive coronary artery detection solutions. The company's flagship product, HeartFlow Analysis, employs artificial intelligence to generate a personalized 3D model of the heart using standard CT scan data. This enables clinicians worldwide to assess the impact of blockages on blood flow and determine optimal patient treatment, thereby reducing unnecessary invasive testing. HeartFlow operates additional offices in Portland (Oregon), Austin (Texas), London (UK), and Tokyo (Japan).

Silna Health

Series A in 2025
Silna Health specializes in streamlining healthcare processes by offering a proactive care readiness platform. This platform ensures patients are eligible for care and handles prior authorizations, benefit checks, and insurance monitoring, thereby enhancing payment certainty and improving patient outcomes. It enables healthcare providers to expedite the process of scheduling appointments, from initial inquiry to booking, by managing these administrative tasks upfront.

Manappuram Finance

Post in 2025
Manappuram Finance Limited is a non-banking financial company based in Thrissur, India, established in 1949. The company specializes in providing a diverse range of retail credit products and financial services, primarily focusing on loans secured by household and used gold jewelry. Its offerings include microfinance loans for low-income individuals, housing loans for construction and improvement, vehicle loans, and loans for the hospitality sector. Additionally, Manappuram Finance provides life and non-life insurance products, IT solutions, and various financial services such as money transfers and foreign exchange. With a significant presence, the company operated 3,531 branches across 23 states and 5 union territories as of March 31, 2020. Formerly known as Manappuram General Finance and Leasing Limited, it rebranded in 2011. The company is led by Shri V.P. Nandakumar, who holds a substantial equity stake.

Norm AI

Series B in 2025
Norm AI is a developer of an AI-powered regulatory compliance platform tailored for the legal and compliance sectors. The company's innovative approach addresses the regulatory sludge problem by transforming complex regulations into autonomous AI agents capable of making compliance determinations. This platform allows compliance teams to delegate tasks to these regulatory AI agents through high-level instructions, ensuring that the resulting work product is validated at various levels of detail. Norm AI's solutions enhance efficiency and accuracy in compliance processes, significantly benefiting organizations navigating intricate regulatory landscapes.

CMIC Holdings

Acquisition in 2025
CMIC Holdings is a Japan-based company founded in 1992 and headquartered in Minato-ku, Tokyo. It operates primarily as a contract research organization (CRO) and offers a diverse range of services tailored to the pharmaceutical and healthcare sectors. These services include contract development and manufacturing (CDMO), contract sales organization (CSO) support, and innovative pharmaceutical models (IPM). CMIC specializes in various aspects of pharmaceutical management, encompassing data management, statistical analysis, medical consulting, medical writing, auditing, and analytical testing. Additionally, the company plays a vital role in facilitating clinical trials and providing human resource services, as well as sales and marketing support, thereby contributing significantly to advancements in medical and healthcare fields.

Charta

Seed Round in 2025
Charta Health is a technology company specializing in medical billing optimization. It employs artificial intelligence to scrutinize patient charts before claims are submitted, ensuring all potential revenue opportunities are captured, claim denials are minimized, and billing standards are consistently met. The platform offers real-time analytics, audits, and autonomous chart reviews, empowering healthcare professionals to enhance administrative efficiency and patient care.

Surf Internet

Private Equity Round in 2025
Surf Internet is a provider of fiber optic and fixed wireless broadband services, catering to residential subscribers, businesses, educational institutions, and municipalities in Indiana, Illinois, and Michigan. The company offers high-speed internet solutions with various plans designed to meet diverse usage needs, ensuring reliable connectivity for activities such as streaming, gaming, and remote work. Surf Internet is committed to expanding its network infrastructure to improve service availability and performance, while also delivering customer support for installation and technical inquiries. Through its efforts, the company aims to enhance the digital landscape of the Great Lakes region and provide better customer service within the communities it serves.

Hightouch

Series C in 2025
Hightouch is a customer data platform that specializes in data synchronization between various marketing and operational tools. The company enables businesses to connect their existing data warehouses with applications such as customer relationship management systems, email marketing platforms, and advertising networks. By providing a user-friendly interface, Hightouch simplifies data integration and management, allowing organizations to access and utilize their data effectively without duplication. This approach helps maintain data integrity and security, while empowering clients to leverage their data for personalized marketing campaigns. Hightouch's platform features audience segmentation, data transformation, and automated workflows, which assist businesses in optimizing their marketing strategies and operational processes.

Solid Biosciences

Post in 2025
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.

Dream Security

Series B in 2025
Dream Security is a cybersecurity company that develops AI solutions to protect against cyber threats. The company provides various cybersecurity services, including AI-driven threat detection to monitor network activity for anomalies, incident response teams to manage and analyze cyber incidents, and vulnerability management through regular assessments and penetration testing. They also offer security awareness training, assist with compliance and risk management to meet regulatory requirements, and provide cloud security solutions for cloud infrastructures. Additionally, the company offers consulting services to help organizations develop and implement cybersecurity strategies.

Apleona

Acquisition in 2025
Apleona is a professional services firm based in Neu Isenburg, Germany, established in 2016. The company specializes in comprehensive real estate services within the DACH region (Germany, Austria, and Switzerland). Its offerings span facility management, building technology, interior fittings, and real-estate management, including commercial services like letting, leasing, and marketing. Apleona caters to a diverse client base comprising banks, investment funds, industrial companies, and insurance firms, aiming to enhance their operational performance across multiple locations.

Abcuro

Series C in 2025
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Established in 2015 and headquartered in Newton, Massachusetts, Abcuro specializes in creating therapeutic antibodies that target novel pathways in these diseases. The company employs advanced bioinformatics to analyze transcription data from human diseases, enabling them to identify new therapeutic targets within the immune system. By leveraging clinical insights and systematic target validation, Abcuro aims to develop immune-modulatory biotherapeutics that provide innovative treatment options for patients suffering from autoimmune disorders and cancer.

Index

Seed Round in 2025
The product-native discovery companion for Linear. Collect feedback, brainstorm ideas, and manage product plans.

SelectQuote

Post in 2025
SelectQuote Insurance Services, Inc. is an insurance company based in San Francisco, California, specializing in a diverse array of insurance products, including term life, auto, home, and Medicare insurance. Founded in 1985, SelectQuote aims to assist families by providing tailored insurance solutions that meet their specific needs and budget. Operating as a subsidiary of SelectQuote, Inc., the company utilizes a direct-to-consumer distribution model, allowing clients to compare rates from a wide range of highly rated insurance providers online. This approach ensures that consumers receive the best possible coverage at competitive prices. SelectQuote generates revenue through commissions earned by selling insurance products on behalf of its carrier partners and operates through four key segments: Senior, Healthcare Services, Life, and Auto & Home.

Mitsubishi Tanabe Pharma

Acquisition in 2025
Mitsubishi Tanabe Pharma Corporation is a pharmaceutical company headquartered in Osaka, Japan, that manufactures and sells a diverse range of drugs across Japan, Europe, North America, and other Asian countries. The company focuses on developing treatments for various medical conditions, including immuno-inflammation, diabetes, kidney diseases, and central nervous system disorders. Its notable products include Simponi for rheumatoid arthritis, multiple diabetes treatments such as Canaglu and Invokana, Radicava for amyotrophic lateral sclerosis, and Gilenya for multiple sclerosis. Additionally, Mitsubishi Tanabe Pharma offers vaccines, including influenza and varicella vaccines, and over-the-counter products. The company collaborates with several organizations to enhance its research and development capabilities. Founded in 1678, it operates as a subsidiary of Mitsubishi Chemical Holdings Corporation.

Milacron Holdings

Acquisition in 2025
Milacron Holdings is a prominent manufacturer and distributor of highly engineered and customized systems within the plastic technology and processing industry, which is valued at approximately $27 billion. The company offers a comprehensive product portfolio that includes injection molding, blow molding, extrusion equipment, and hot runner systems, positioning itself as the only global entity with such a full-line offering. Milacron's operations are divided into three segments: Advanced Plastic Processing Technologies, Melt Delivery and Control Systems, and Fluid Technologies. The Advanced Plastic Processing Technologies segment focuses on the design and manufacture of various molding equipment and related services, while the Melt Delivery and Control Systems segment produces hot runner and process control systems, along with maintenance, repair, and operating supplies for plastic processing equipment. The Fluid Technologies segment specializes in synthetic and semi-synthetic lubricants and coolants for industrial metalworking applications. With a diverse customer base exceeding 27,000, Milacron maintains strong market shares in North America and emerging markets like China and India.

MagicSchool

Series B in 2025
MagicSchool is a technology company that specializes in providing artificial intelligence-driven tools to support educators. Its comprehensive platform offers over 60 AI tools designed to assist teachers in various aspects of their profession, including lesson planning, assessment creation, differentiation, and communication. By generating original, tailored educational content, feedback, and recommendations, MagicSchool aims to enhance educators' productivity and effectiveness.

Archive

Series B in 2025
Archive is a technology company specializing in the development of customized resale programs that empower brands to manage their secondhand markets effectively. Collaborating with notable brands, Archive creates tailored resale experiences aimed at extending the lifecycle of clothing while generating additional revenue and enhancing customer loyalty. The company leverages advanced technology and design capabilities to offer flexible solutions that cater to the unique needs of each brand. Its platform supports various resale models, including peer-to-peer transactions, take-back programs, returns, and brand-owned inventory. By providing proprietary item intelligence software, Archive enables brands to establish comprehensive resale operations that maximize profitability and minimize environmental impact, facilitating the buying and selling of pre-owned fashion items at accessible prices.

Frontline Road Safety

Acquisition in 2025
Frontline Road Safety provides pavement marking services to a variety of end markets and customers. It's companies provide a range of services, including seal coating, pressure washing, and parking lot striping. The company was formed in 2020 by the private equity firm Sterling Group.

Dhoot Transmission P

Private Equity Round in 2025
Dhoot Transmission Pvt. Ltd. is an Indian conglomerate specializing in the manufacture and provision of various automotive components, including wiring harnesses, electronic sensors, controllers, and automotive switches. The company also produces power cords and offers solutions for cable systems, copper wires, and tooling for electronics, stamping, and molding systems. With 23 manufacturing facilities worldwide, Dhoot Transmission serves a diverse customer base across eight countries and three continents. The company is ISO certified and has expanded its operations through strategic acquisitions within the industry. During the COVID-19 pandemic, Dhoot Transmission successfully resumed operations while adhering to health and safety guidelines.

Jamco

Acquisition in 2025
Jamco is a Japan-based company specializing in the manufacture of components for the aviation industry, particularly focusing on aircraft engines and interiors. The company operates through several business divisions, including Aircraft Interiors, Aircraft Seats, Aircraft Components, and Aircraft Maintenance. Its Aircraft Interiors division produces essential products such as galleys and lavatories for passenger aircraft, while the Aircraft Seats division specializes in the design and manufacture of passenger seating solutions. Additionally, the Aircraft Components division focuses on the production of critical equipment like heat exchangers. Jamco also provides maintenance services, ensuring that aircraft operate safely and comfortably. Through its innovative technologies, Jamco contributes significantly to enhancing the passenger experience in air travel.

Timberlyne Therapeutics

Series A in 2025
Timberlyne Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for autoimmune diseases. It leverages its team's expertise in drug development to acquire promising assets targeting unmet medical needs. The company specializes in monoclonal antibodies with enhanced complement-dependent cytotoxicity, specifically targeting CD38, a protein highly expressed in various immune cells. This approach enables rapid and durable responses across a range of autoimmune diseases.

Cofactr

Series A in 2024
Cofactr, founded in 2021 by Matthew Haber and Phillip Gulley in New York, specializes in supply chain automation and procurement optimization for critical industries such as aerospace, defense, medtech, and robotics. The company offers an automated electronics purchasing assistant that aids hardware teams in sourcing necessary components by connecting them with global suppliers. Cofactr's platform features powerful supply chain intelligence, intuitive forecasting, transparent search capabilities, automated quoting, and instant purchasing. By streamlining these processes, Cofactr enables clients to proactively address sourcing challenges and reduce supply issues, ensuring the timely delivery of essential hardware.

Mayapada Hospital

Post in 2024
Mayapada Hospital offers health and hospital management services. They provide a range of services ranging from diagnosis, therapy, surgery, and rehabilitation to comprehensive care and control of neurological disorders. They offer clinical services and medical consultations for digestive tract problems. Their paediatric centre also provides physical check-ups, vaccinations, and treatment for specific paediatric symptoms, heart failure, and orthopaedic disorders.

Angitia Biopharmaceuticals

Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to the discovery and development of innovative therapeutics targeting serious musculoskeletal diseases. The company specializes in researching and developing breakthrough therapies for conditions affecting bones, muscles, and joints. By focusing on creating novel drugs, Angitia aims to provide effective treatments that enhance patient recovery from severe musculoskeletal ailments.

Pollo Tropical

Debt Financing in 2024
Pollo Tropical has been committed to providing fresh, great-tasting dishes in its kitchens every day. Authentic preparation, fresh ingredients, and a creative touch on traditional flavors are the perfect mix for delicious, craveable food.

Wrightwell

Private Equity Round in 2024
Wrightwell operates as a services platform that offers customizable, institutional access to a multi-trillion-dollar asset class to investors of all types and sizes. The company's services are primarily focused on asset management, construction, financial services, and real estate. Vantage's Single Family Rental (SFR) Services, backed by proprietary technology, empower investors to make SFR a significant part of their portfolio. The company also assists clients in determining leasing criteria and guidelines, such as background checks, employment documentation, and credit score minimums.

Olema Oncology

Post in 2024
Olema Oncology is a preclinical biotechnology company dedicated to developing innovative therapies for the treatment and prevention of estrogen receptor-positive breast cancer. The company specializes in discovering and commercializing targeted treatments specifically designed for women's cancers. By leveraging its extensive understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance, Olema aims to create compounds that surpass existing therapies. The company's focus is on transforming the standard of care for both pre- and post-menopausal women with cancer, with an emphasis on developing more effective and convenient treatment options. Olema's pipeline includes drug candidates such as OP-1250 and OP-3136, which have progressed through discovery and preclinical studies.

Oak Reinsurance

Seed Round in 2024
OAK Re is an international provider of reinsurance.

Halcyon

Series C in 2024
Halcyon is a cybersecurity company that specializes in protecting enterprise clients from ransomware attacks. The firm has developed a comprehensive platform that provides layered ransomware protection through a combination of pre-execution detection, behavioral modeling, and deception techniques. This approach not only enhances resilience against cyber threats but also facilitates recovery and isolation of affected nodes, making it an essential solution for mid-market and larger organizations seeking to safeguard their digital assets from the growing risk of ransomware.

VISO TRUST

Venture Round in 2024
VISO Trust is a San Francisco-based company founded in 2016 that specializes in vendor security due diligence. The company has developed a platform that provides comprehensive and actionable information regarding vendor security risks. This platform enables decision-makers to conduct informed risk assessments and make sound security choices by streamlining the vendor review process. By delivering reliable data, VISO Trust assists enterprises in managing third-party security risks effectively and transparently, ultimately enhancing their overall cybersecurity posture.

Northflank

Series A in 2024
Northflank Ltd., founded in 2013 and based in London, United Kingdom, develops a next-generation cloud hosting platform that provides a self-service environment for developers to build, run, and scale applications. The company specializes in platform as a service through application programming interfaces, supporting various workloads and facilitating integration with multiple cloud providers. Northflank's automated development operations platform offers a suite of services, including continuous integration, delivery, deployment, and data processing. By enabling efficient deployment and management of applications, Northflank aims to reduce costs and enhance operational effectiveness for organizations leveraging cloud technology at scale.

Lean Technologies

Series B in 2024
Lean Technologies Limited is a FinTech startup founded in 2019 and based in Riyadh, Saudi Arabia. The company specializes in developing an application programming interface (API) platform that facilitates access to consumer financial data. Its API suite addresses the complexities of fragmented financial infrastructure, allowing businesses to easily access their customers' financial information and execute instant bank transfers. Lean Technologies aims to improve the accessibility, transparency, and functionality of financial data and payment systems, contributing to a more inclusive and interconnected financial ecosystem for both consumers and businesses.

AQ Compute

Acquisition in 2024
AQ Compute, established in 2020 and headquartered in Hamburg, Germany, specializes in providing customized compute capacities powered by clean energy. The company offers modular data center and colocation services, leveraging artificial intelligence technology to support various computer, storage, and GPU applications. AQ Compute's mission is to decarbonize the colocation and data center industry, enabling clients to build sustainable, zero-emissions data centers.

The Openwork Partnership

Private Equity Round in 2024
The Openwork Partnership is a provider of financial advice services.

Decagon

Series B in 2024
Decagon offers AI customer support agents designed for enterprises. It is trusted by leading companies and startups, their generative AI delivers exceptional customer experiences. It provides auto-resolve issues, streamlines workflows, assists agents and gains powerful insights with seamless integrations tailored for success.

EvenUp

Series D in 2024
EvenUp is a legal technology company that specializes in cloud-based and AI-driven solutions for managing personal injury cases. The company offers a platform that automates various aspects of legal practices, particularly in valuing personal injury claims. By leveraging its Claims Intelligence Platform, which is underpinned by extensive data records, EvenUp enhances the efficiency and effectiveness of legal case management. Its software employs machine learning and artificial intelligence to assess the worth of lawsuits, helping plaintiffs secure fair outcomes and avoid premature settlements or excessive debts. Additionally, the platform provides attorneys with valuable data to facilitate principled settlement negotiations.

Pallet

Series A in 2024
Pallet develops supply chain software that provides comprehensive visibility, automation, control, and optimization for end-to-end logistics. Its flagship product integrates a Transportation Management System (TMS) and Warehouse Management System (WMS), designed to streamline and enhance business operations.

Kailera Therapeutics

Series A in 2024
Kailera Therapeutics is a biotechnology company focused on developing innovative treatments for obesity and associated conditions. It specializes in injectable and oral GLP-1 (Glucagon-like peptide-1) therapies, aiming to provide patients with transformative health solutions.

T-Gaia

Acquisition in 2024
T-Gaia is a telecommunications company based in Japan that operates primarily in three segments: Mobile, Solution, and Settlement Services. The company engages in the sales and distribution of mobile phones and offers corporate customers various solution services, including brokerage services for fixed-line communication and broadband services. T-Gaia has a significant presence in the prepaid market, selling prepaid cards and codes, primarily through convenience stores, which have been steadily expanding. Additionally, the company provides a nationwide electronic payment system and distributes gift cards in Singapore through its subsidiaries.

Zenlytic

Series A in 2024
Zenlytic is a business intelligence platform that focuses on enhancing data accessibility and analysis for e-commerce businesses. Central to its offering is Zoë, an advanced data analyst chatbot that significantly streamlines the data request process, reducing ad hoc requests by over 80% and providing answers 1200 times faster than traditional data teams. Zenlytic's platform is designed as a no-code tool that automatically identifies critical changes in data, presents insights in a user-friendly manner, and allows for in-depth exploration of the factors influencing key metrics. By developing a unique LLM-native semantic layer and integrating it with a powerful AI agent, Zenlytic provides clients with a comprehensive understanding of their business through intuitive dashboards and advanced analytics, all communicated in plain English.

Serán Bioscience

Private Equity Round in 2024
Serán Bioscience is a contract development and manufacturing organization that specializes in providing a wide range of services to pharmaceutical and biotechnology companies. The company offers a comprehensive suite of development, analytical, and clinical manufacturing services, aimed at optimizing drug development and production processes. By catering to various aspects of pharmaceutical development, Serán Bioscience supports its clients in efficiently bringing their products to market.

Digital Media Solutions

Private Equity Round in 2024
Digital Media Solutions is a leading performance marketing company that leverages actionable data, insightful analytics, and proprietary technology to help clients reach, engage, and acquire customers across various interactive platforms. With a focus on precision targeting and customer acquisition, DMS caters to top brands in competitive industries, offering a range of performance marketing, digital agency services, and marketing technology solutions. Through meticulous execution and a suite of proprietary assets, Digital Media Solutions delivers effective marketing strategies to drive client success.

Mintlify

Series A in 2024
Mintlify is a company that specializes in creating AI-powered code documentation platforms. It assists developers in generating beautiful, current, and engaging documentation directly from their codebase, eliminating the need for manual documentation writing. This approach saves developers time and enhances the overall quality of their documentation. Mintlify's platform is trusted by over 7000 companies, including notable names like Anthropic, Cursor, Perplexity, Scale, and Zapier, demonstrating its effectiveness in helping users quickly understand and utilize new products.

AutoComplete

Seed Round in 2024
AutoComplete, Inc. is an insurance-technology company headquartered in San Francisco, California. It focuses on integrating artificial intelligence at the point of sale, specifically targeting the substantial car insurance market valued at $311 billion. The company has developed an AI-driven platform that simplifies the process of obtaining auto protection, aiming to enhance the user experience by minimizing effort in securing automotive insurance. Through its innovative software, AutoComplete seeks to provide efficient solutions that redefine how consumers engage with auto insurance services.

Contextual AI

Series A in 2024
Contextual AI offers a pioneering approach to generative AI for the workplace.

Imperative Care

Series E in 2024
Imperative Care, Inc. is a medical technology company based in Campbell, California, established in 2015. The company specializes in developing innovative solutions aimed at enhancing the diagnosis, treatment, and rehabilitation of stroke patients. Its primary offerings include the Large Distal Platform, a catheter designed to facilitate access to treatment sites for both ischemic and hemorrhagic stroke procedures, and the ZOOM Aspiration System, which works in conjunction with the Large Distal Platform to provide a comprehensive solution for clot removal across various occlusion sizes. By focusing on improving the speed and effectiveness of acute stroke treatment, Imperative Care aims to address significant unmet needs in stroke care, ultimately providing patients with better prospects for recovery.

Somacis

Acquisition in 2024
Somacis SpA specializes in the manufacturing and supply of printed circuit boards (PCBs), including rigid, flex, and rigid-flex types. The company is recognized for its expertise in high-density interconnect (HDI) and flex-rigid PCBs, offering solutions that accommodate up to 50 layers. Somacis provides a range of products such as buried components, metal core solutions, RF/microwave products, graphic overlays, touch screens, and custom membrane switches. Founded in 1972 and headquartered in Castelfidardo, Italy, Somacis operates additional production facilities in Manfredonia, Italy; Poway, California; and Guangdong, China. The company serves various industries, including telecommunications, aerospace, defense, industrial, medical, automotive, and information technology, catering to both time-sensitive and mass production needs.

Kestra Medical Technologies

Private Equity Round in 2024
Kestra Medical Technologies, Inc. is a company that specializes in developing and manufacturing wearable medical devices aimed at monitoring and managing acute medical conditions. Founded in 2014 and headquartered in Kirkland, Washington, the company offers solutions that enable the collection, communication, and storage of patient performance data, facilitating both real-time and retrospective analysis. Among its key products are wearable cardioverter defibrillators designed to prevent sudden cardiac death and aid in the recovery of at-risk cardiac patients. By focusing on intuitive and mobile diagnostic and therapeutic technologies, Kestra Medical Technologies strives to enhance patient care and support healthcare teams in effectively managing patient health.

Momento

Series A in 2024
Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide. Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.

MRO Holdings

Private Equity Round in 2024
MRO Holdings is a company that specializes in aircraft maintenance, modifications, and conversions, offering a comprehensive suite of technical solutions for the aviation industry. Its services encompass airframe maintenance, engineering, and the development of maintenance programs and reliability strategies. By focusing on long-term applications within the aircraft maintenance sector, MRO Holdings aims to create a stable and challenging work environment for aviation professionals, emphasizing a strong culture of safety, quality, and performance.

Savara Pharmaceuticals

Post in 2024
Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

Pomerium

Series A in 2024
Pomerium is a developer of identity-aware proxy software that enhances security by providing controlled access to internal applications without the need for a virtual private network (VPN). The company's software offers a standardized interface that facilitates user authentication, authorization, and monitoring for any application, allowing enterprises to secure access to both internal and external applications. By streamlining access control processes, Pomerium enables developers to concentrate on their applications without the burden of reinventing access management solutions.

Bapcor

Private Equity Round in 2024
Bapcor is a leading provider of automotive aftermarket parts, accessories, and services in Australasia, primarily operating in Australia and New Zealand. The company specializes in the distribution of automotive spare parts through its Trade, Retail & Service, and Specialist Wholesale segments. Its Trade businesses include Burson Auto Parts and BNT, which offer a vast selection of car parts for over 400 vehicle makes and models. In the Retail & Service sector, Bapcor operates brands such as Autobarn, Autopro, and Sprint Auto Parts, catering to the do-it-yourself market, as well as service-oriented businesses like Midas and ABS. Additionally, its Specialist Wholesale segment focuses on providing specialized automotive parts. Through these diverse offerings, Bapcor serves both independent and chain mechanic workshops, establishing itself as a significant player in the automotive aftermarket industry.

Cube Dev

Series B in 2024
Cube Dev, Inc., established in 2016 and headquartered in San Francisco, specializes in designing and developing open-source analytical API platforms. The company offers tools for building visualization-agnostic user interfaces, analytical API servers, and supports modern data stores. Its flagship product, Cube Cloud, provides managed infrastructure, query inspection and tracing, pre-aggregation management, and monitoring capabilities. Cube Dev's platform enables businesses to build internal business intelligence tools and add customer-facing analytics to existing applications, handling large datasets securely and efficiently.

CereVasc

Series B in 2024
CereVasc, Inc. is a medical device company based in Auburndale, Massachusetts, specializing in the development of innovative, minimally invasive treatments for neurological diseases. The company has created the eShunt System, an endovascularly deliverable cerebrospinal fluid (CSF) shunt designed to replace traditional surgical methods for treating communicating hydrocephalus. This system aims to eliminate the need for invasive surgery, general anesthesia, and hospitalization, which are typically associated with the conventional use of ventriculo-peritoneal shunts. By providing a less invasive alternative, CereVasc seeks to improve patient outcomes and reduce the overall costs related to the surgical management of life-threatening neurological conditions. Established in 2014, CereVasc is focused on advancing healthcare solutions that enhance the treatment of various neurological brain disorders.

Sikich

Private Equity Round in 2024
Sikich is a Chicago-based accounting firm established in 1982 that provides a wide range of services, including accounting, auditing, tax planning, and information technology managed services. The firm also has a dedicated investment banking division that specializes in mergers and acquisitions, as well as capital raising for corporations, private equity firms, and entrepreneurs. Sikich serves various sectors, including healthcare and life sciences, agriculture, construction, manufacturing, technology, education, and retail, offering tailored financial and strategic advisory services to meet the unique needs of its clients.

Ansa

Series A in 2024
Ansa is a technology company that specializes in developing a closed-loop payment platform aimed at enhancing customer loyalty for businesses. Its innovative technology enables marketers to create customer balances, load funds, and gain valuable insights into consumer spending habits. By financing customer accounts, Ansa's platform helps businesses reduce payment costs, increase transaction values, and foster repeat transactions. This approach supports brands in retaining and rewarding loyal customers, ultimately driving growth and profitability.

Prophet Security

Seed Round in 2024
Prophet Security provides security operations by automating the triage, investigation, and response process.

Century Therapeutics

Post in 2024
Century Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies derived from induced pluripotent stem cells (iPSCs) to treat hematologic and solid malignancies. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a specialized platform that integrates gene editing and protein engineering to create allogeneic therapies. This platform allows for the generation of master cell banks of modified immune effector cells, specifically engineered to optimize performance and reduce the risk of rejection by the host immune system. By employing advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to address significant unmet medical needs in cancer and other diseases.

Homebase

Series D in 2024
Homebase is a developer of employee management software focused on simplifying the administrative tasks associated with hourly work. The platform offers tools for scheduling, time tracking, and communication, all designed to minimize the burden on employers and employees alike. Its cloud-based system allows users to manage timesheets and track hours from any location, facilitating efficient payroll preparation. While the basic features are available for free, Homebase also provides tiered pricing options for businesses seeking additional functionalities. By streamlining these processes, Homebase aims to help organizations save time and improve coordination among their teams.

Xilio Therapeutics

Post in 2024
Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies, utilizing its proprietary technology to maximize the effectiveness of immuno-oncology treatments while minimizing side effects outside the tumor. Among its key products is XTX201, which aims to induce immune activity directly within tumors, demonstrating improved antitumor effects. Founded in 2015 and based in Waltham, Massachusetts, Xilio Therapeutics was previously known as Akrevia Therapeutics until its rebranding in March 2020. The company is dedicated to advancing a pipeline of novel immuno-oncology molecules, including tumor-activated cytokines and antibodies, with the goal of significantly improving patient outcomes in cancer treatment.

Gather AI

Series A in 2024
Gather AI is an autonomous inventory management platform that specializes in providing inventory as a service for modern warehouses. Founded in 2017 and headquartered in Pittsburgh, Pennsylvania, the company offers a comprehensive solution that combines its proprietary software with off-the-shelf drones, allowing businesses to automate inventory tasks effectively. The software is designed to operate safely in environments without GPS, utilizing artificial intelligence to facilitate data analytics and inventory monitoring. With a team of PhDs and research engineers from the Carnegie Mellon Robotics Institute, Gather AI aims to enhance operational efficiency for its clients by enabling seamless inventory management and monitoring.

Loyal

Series B in 2024
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the health span and lifespan of dogs. The company creates medicines designed to delay the onset of age-related diseases such as cancer, heart disease, and metabolic disorders. By quantifying and regulating the aging process, Loyal seeks to mitigate the effects of aging, thereby promoting healthier and longer lives for dogs. Through its innovative approach, the company aspires to improve the quality of life for pets and enhance their longevity.

Unstructured

Series B in 2024
Unstructured is a developer of an open-source data transformation platform that simplifies the process of converting raw data, such as PDFs and Microsoft Office documents, into formats compatible with language models. The platform supports over 25 file types, including PDF, DOC, and PPTX, and offers connectors to various systems like SharePoint, S3, and Databricks. By facilitating effortless data extraction and integration into AI workflows, Unstructured enhances the accessibility of human-generated information, ensuring that it is readily available for generative AI systems. Its modular architecture allows users to incorporate any third-party model, making it a versatile solution for preprocessing natural language data for machine learning applications.

Fermat Commerce

Series A in 2024
Fermat Commerce operates an influencer-driven e-commerce platform designed to enhance brand sales and provide a seamless shopping experience for end-users. The platform enables content creators to embed brand-direct shopping features on their websites, allowing customers to purchase products without leaving the creators' content. By offering e-commerce enablement software, Fermat Commerce supports both merchants and content creators in building and managing their online stores, thereby facilitating a direct connection between brands and consumers within a creator's online environment.

Argyle

Series C in 2024
Argyle is a developer of a payroll connectivity platform that aims to enhance financial services through the provision of real-time income and employment data. The platform automates various functions, including verifications, background checks, account funding, direct deposit switching, premium calculations, and wage advancements. By facilitating these processes, Argyle enables businesses and financial institutions to streamline onboarding and account management, ultimately improving efficiency and user experience in the financial services sector.

Relay

Series B in 2024
Relay is an-all-in-one, collaborative business banking and money management platform that helps small businesses and their teams take control of their cash flow and get crystal clear on what they’re earning, spending and saving. With Relay, business owners can: -Bank with no monthly account fees, no overdraft fees, and no minimum balance required -Organize income, expenses and cash reserves using up to 20 individual accounts -2 savings accounts offering between 1-3% APY -Issue up to 50 virtual or physical Visa® debit cards to meticulously organize spending by team or project -Send payments and deposits via ACH, wires or checks -Cashflow automations, like maximum balance transfer rules and recurring payments -Give team members and financial advisors secure, role-based banking access -Integrate banking with accounting softwares like QuickBooks Online and Xero -Get personalized customer support by email and phone Relay is also the official banking partner of Profit First, the cash flow management methodology and book created by serial entrepreneur Mike Michalowicz.

GigEasy

Pre Seed Round in 2024
GigEasy is a technology company developing an insurance and benefits platform tailored to the gig economy. Its platform offers flexible coverage options, including health, dental, and vision plans, with on-demand activation and competitive pricing. GigEasy's API enables businesses to integrate insurance directly into their platforms, allowing gig workers to safeguard their income and businesses to provide attractive benefits packages.

Areteia Therapeutics

Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing innovative treatments for asthma, particularly eosinophilic asthma. Spun out from Knopp in Pennsylvania, the company aims to empower asthma patients by providing them with better control over their condition. Areteia is advancing an oral drug candidate that works by inhibiting the maturation of eosinophils, which are immune cells that can damage the airways and exacerbate asthma symptoms. The drug has shown promise in clinical trials, with results indicating its potential to reduce blood eosinophil counts, a key marker associated with improved lung function. This breakthrough could offer a much-needed accessible treatment option for millions of individuals suffering from this severe form of asthma, allowing them to manage their disease more effectively and improve their quality of life.

Navro

Venture Round in 2024
Navro is a fintech company that specializes in providing payment and banking infrastructure for software businesses. It offers a platform that enables brands to scale their payment operations globally by integrating various financial services such as international payment acceptance, local fund collection, and real-time coverage. Navro's solution allows businesses to manage their payment stack efficiently, facilitating international growth.

Branching Minds

Private Equity Round in 2024
Branching Minds, Inc. is a New York-based company that offers a web-based platform designed to assist educators and parents in identifying and addressing students' learning challenges. Incorporated in 2013, the company provides tools that facilitate the collection of data on observable student behaviors through a structured Q&A process. This allows educators to pinpoint cognitive issues and strengths effectively. The platform further enhances the educational process by algorithmically matching identified challenges with research-backed supports, thereby enabling personalized interventions. Additionally, it equips learning specialists, psychologists, and special educators with the ability to track observations, systematize record-keeping, and generate reports on student progress, ultimately improving the response to intervention and multi-tier systems of support in educational settings.

Accolade Wines

Acquisition in 2024
Accolade Wines is a prominent global wine business headquartered in South Australia. It is recognized as the leading wine company in both Australia and the United Kingdom by volume and ranks as the fifth largest wine company worldwide. With a rich heritage dating back to one of the first wineries established in Australia in 1853, Accolade Wines has developed a diverse portfolio that includes some of the most renowned wine brands in the market. The company specializes in the production and distribution of a wide range of wines, contributing significantly to the global alcoholic beverage industry.

Solid Biosciences

Post in 2024
Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.

Avistone Pharmaceuticals

Series B in 2023
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

Halcyon

Series B in 2023
Halcyon is a cybersecurity company that specializes in protecting enterprise clients from ransomware attacks. The firm has developed a comprehensive platform that provides layered ransomware protection through a combination of pre-execution detection, behavioral modeling, and deception techniques. This approach not only enhances resilience against cyber threats but also facilitates recovery and isolation of affected nodes, making it an essential solution for mid-market and larger organizations seeking to safeguard their digital assets from the growing risk of ransomware.

Syros Pharmaceuticals

Post in 2023
Syros Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in developing innovative treatments for cancer and monogenic diseases through gene control medicines. The company is advancing its lead product candidates, including SY-1425, a selective retinoic acid receptor alpha agonist currently in Phase II clinical trials for specific patient populations with acute myeloid leukemia and myelodysplastic syndrome, and SY-5609, a cyclin-dependent kinase 7 inhibitor under investigation in a Phase I clinical trial for advanced solid tumors. Syros is also engaged in collaborative research, including a partnership with Incyte Corporation aimed at identifying therapeutic targets for myeloproliferative neoplasms and a licensing agreement with TMRC Co. Ltd. for the development of tamibarotene. With a focus on mapping gene regulatory circuits, Syros leverages its proprietary platform and expertise to address significant unmet medical needs in oncology. Founded in 2011, the company aims to establish new standards of care for patients with hematologic malignancies.

1440 Foods Company

Acquisition in 2023
1440 Foods Company is dedicated to fostering a healthier community by offering a diverse portfolio of sports and active nutrition products. The company specializes in health and wellness brands that provide efficacy-driven protein powders, meal replacements, and lifestyle products aimed at promoting balanced nutrition. Through its focus on powerful and complementary growth brands, 1440 Foods seeks to inspire individuals to realize their potential and enhance their overall well-being.

Andalusia Labs

Series A in 2023
Andalusia Labs is focused on creating foundational digital infrastructure tailored for internet markets, particularly in the realm of digital assets. The company develops a comprehensive risk management infrastructure that includes a security platform and a risk management marketplace. This infrastructure is designed to assist the blockchain market in effectively managing substantial amounts of digital assets, thereby supporting innovative companies worldwide. Through its offerings, Andalusia Labs aims to enhance the security and stability of digital asset transactions and management.

Eleda Group

Acquisition in 2023
Eleda Group specializes in engineering, excavation, and construction services focused on critical infrastructure sectors, including water, heating, and transportation. The company provides a wide range of services, from complete project contracts to machinery leasing. Its expertise extends to building and maintaining the electricity grid, as well as developing hydro and wind power plants, which are essential for supporting the electrification and digitalization of society. Eleda operates through local companies that are leaders in their respective markets, enabling them to handle projects of various scales, from smaller assignments to comprehensive contracts.

MaintainX

Series C in 2023
MaintainX, Inc. is a technology company that specializes in developing a frontline record management platform designed for maintenance and facility management teams. Founded in 2018 and headquartered in San Francisco, California, MaintainX offers a software as a service (SaaS) solution that digitizes workflows and enhances collaboration and analytics for various industries, including manufacturing, hospitality, and food service. The platform provides tools for work order management, environmental and training checklists, auditing and inspection workflows, and quality control processes. It also facilitates communication among users and allows for the uploading of photos, enabling more efficient operations and improved asset management. MaintainX aims to empower frontline workers by providing them with a mobile-first solution that delivers real-time insights and supports regulatory compliance.

Eyebiotech

Series A in 2023
Eyebiotech is a vision treatment company that develops products to preserve, repair, and improve eyesight. The firm guards against sight-threatening eye disorders and developed the first anti-vascular endothelial growth factor medication for patients with age-related macular degeneration, allowing those with eye ailments to regain their eyesight.

Gynesonics

Venture Round in 2023
Gynesonics, Inc. is a medical device company focused on developing innovative solutions for women's health, specifically addressing symptomatic uterine fibroids. Founded in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, Gynesonics offers the Sonata System, a minimally invasive treatment that utilizes sonography guidance for the transcervical ablation of fibroids. This incision-free approach provides a safe and effective alternative to traditional surgical methods such as hysterectomy or myomectomy, aiming to alleviate severe menstrual symptoms associated with fibroids. Gynesonics is dedicated to improving the quality of care for women by offering advanced technologies that enhance treatment options in gynecology.

Aiolos Bio

Series A in 2023
Aiolos Bio is a biotechnology company specializing in the development of therapies for respiratory diseases and immune conditions. Its primary focus is on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma, designed for dosing every 6 months. The company, founded by industry veterans, aims to address unmet treatment needs and improve patient outcomes by providing more efficacious and less burdensome therapies.

Aleph

Series A in 2023
Aleph operates a financial planning and analysis platform designed to enhance the capabilities of traditional spreadsheets such as Excel and Google Sheets. By integrating data from accounting systems and various operational sources, Aleph provides specialized financial tools that are always current. This allows clients to create sophisticated financial models and use cases, ultimately facilitating informed investment decisions. Aleph aims to support finance departments by merging the familiarity of spreadsheets with advanced financial insights, making it a valuable resource for financial professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.